ema prac naion semaglutide june 2025 Eye disorder is a 'very rare' side effect of weight-loss drugs, concludes review Semaglutide linked to increased risk

I will give it a month to see how it goes

Overeating while on GLP-1 RAs can lead to significant discomfort

Meanwhile, TikTok said it does not allow medical items that require a prescription, or slimming and fat loss products

Luzzatti stresses that protecting the community pharmacy infrastructure is a structural necessity for the healthcare system, not an idealist's preference

Key medications that slow CKD progression: ACE inhibitors & ARBs cornerstone therapy to reduce proteinuria and protect kidney function SGLT2 inhibitors originally for diabetes, now proven to reduce CKD progression and hospitalizations for heart failure GLP-1 receptor agonists improve glycemic control and show cardiovascular and kidney benefits Non-steroidal MRAs (finerenone) a new option to reduce albuminuria and improve outcomes in diabetic CKD These therapies, when used together and tailored to the patient, represent a modern stack of treatments that can delay or even prevent kidney failure

This offers an alternative for patients unable to administer injections or who may be prone to certain skin infections that frequent injections could exacerbate